Cell News and Research

RSS

Cancer Research UK honors Nottingham scientist with prestigious award

A University of Nottingham scientist who uses fruit flies to study the genetics of cancer has won a prestigious award from Cancer Research UK.

3 Aug 2011

Autophagy research offers clues to new weight loss treatment

According to a new study when the body is starved brain cells along with other parts of the body begin to eat themselves. The body responds by producing fatty acids, which turn up the hunger signal in the brain and increase the impulse to eat.

3 Aug 2011

GSK, NPS enter agreement to evaluate ronacaleret in new indications

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today reported that it has entered into a new agreement with GlaxoSmithKline (GSK), that terminates and replaces a prior collaborative research and license agreement between NPS and GSK from 1993, which focused on the discovery and development of small molecule antagonists of the calcium receptor that increase secretion of parathyroid hormone.

3 Aug 2011

Pfizer second-quarter revenues decrease 1% to $17.0 billion

Pfizer Inc. today reported financial results for second-quarter 2011. As a result of Pfizer's decision to sell the Capsugel business, all revenues and expenses related to Capsugel in all periods presented are reflected in a single line, Discontinued operations - net of tax.

3 Aug 2011

Scientists look to create blood platelets from stem cells to study genetics of blood clotting disorders

Johns Hopkins scientists have launched a pioneering research program to create, for the first time, human platelet cells from stem cells in order to study inherited blood clotting abnormalities ranging from clots that cause heart attacks and stroke to bleeding disorders. The study is funded by a $9 million grant from the National Institutes of Health (NIH) as part of a nationwide initiative to examine how genetic variations cause heart, lung and blood diseases.

2 Aug 2011

ARIAD reports $47.8 million net loss for second quarter 2011

ARIAD Pharmaceuticals, Inc. today reported financial results for the second quarter and six months ended June 30, 2010 and provided an update on corporate developments.

2 Aug 2011

Simple ways to minimize health risks associated with cell phones

The dangers of cell phones have led to preventive policies in France, Israel, Finland, and India, and there are simple ways to minimize the health risks associated with exposure to the radiation energy they emit, according to Devra Lee Davis, PhD, MPH, President of the Environmental Health Trust, in a timely and informative interview featured in Alternative and Complementary Therapies, published by Mary Ann Liebert, Inc.

2 Aug 2011

New cold electron source could improve quality and speed of nanoimaging for drug development

A new source of very cold electrons will improve the quality and speed of nanoimaging for drug and materials development to a trillionth of a second.

2 Aug 2011

BD third quarter revenues increase to $2.014 billion

BD, a leading global medical technology company, today reported quarterly revenues of $2.014 billion for the third fiscal quarter ended June 30, 2011, representing an increase of 10.0 percent from the prior-year period.

From BD (Becton, Dickinson and Company) 2 Aug 2011

Lack of TLR1 surface expression linked with increased susceptibility to tuberculosis

Are you genetically predisposed to tuberculosis? Scientists may now be able to answer this question and doctors may be able to adjust their therapeutic approach based on what they learn. That's because new research presented in the Journal of Leukocyte Biology suggests that two frequent mutations in an immune system gene called TLR1 are responsible for cellular changes that ultimately make us less likely to resist the disease.

2 Aug 2011

Positive results from Jennerex JX-594 proof-of-concept trial on metastatic melanoma

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, today announced that positive results from a proof-of-concept clinical trial using JX-594 to treat patients with metastatic melanoma were published in the peer-reviewed journal Molecular Therapy.

2 Aug 2011

Blocking IGF-1 receptor cripples cancer growth in T cell acute lymphoblastic leukemia

Blocking a growth factor receptor cripples cancer growth in a form of T cell leukemia, according to a study published online on August 1 in the Journal of Experimental Medicine.

2 Aug 2011

Taxoxifen combined with dasatinib reverses chemo-resistance in breast cancer cells

Taking a leukemia chemotherapy drug may help breast cancer patients who don't respond to tamoxifen overcome resistance to the widely-used drug, new research from the Kimmel Cancer Center at Jefferson suggests.

2 Aug 2011

Ursodeoxycholic acid could help prevent disturbances in heart's normal rhythm

A synthesised compound which is also found in bear bile could help prevent disturbances in the heart's normal rhythm, according to research published today in the journal Hepatology by a team from Imperial College London.

2 Aug 2011

Scientists design octapeptides to fight drug resistant ovarian cancer cells

Italian and German scientists have designed peptides to target the protein-protein interface of a key enzyme in DNA synthesis crucial for cancer growth. The peptides act by a novel inhibitory mechanism and curb cancer cell growth in drug resistant ovarian cancer cells.

2 Aug 2011

Elsevier launches new interactive feature for life sciences journals

Elsevier, a world-leading provider of scientific, technical and medical information products and services, introduces the Genome Viewer, a new interactive feature on SciVerse ScienceDirect for applicable life sciences journals.

2 Aug 2011

Alnylam second quarter revenue decreases to $20.6 million

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter 2011, and company highlights.

From Precision NanoSystems Inc. 2 Aug 2011

Pregnancy and electromagnetic fields linked to asthma in kids

According to American researchers, children whose mothers had high exposure to electromagnetic fields while pregnant may have an increased risk of developing asthma. Many prior studies have failed to consistently show that chronic exposure to electromagnetic fields - from power lines and appliances such as microwaves ovens, hair dryers and vacuum cleaners - are harmful to human health.

1 Aug 2011

Drink wine to prevent sunburns: Flavonoid research

According to a new Spanish study wine could protect against harmful sunburns. The researchers from the University of Barcelona and the Spanish National Research Council find that a compound found in grapes or grape derivatives may protect skin cells from skin-damaging ultraviolet radiation.

1 Aug 2011

Mathematical model predicts progress of tumors from early stages to metastasis

Researchers from the University of Miami (UM) and the University of Heidelberg in Germany have developed a mathematical model to understand and predict the progress of a tumor, from its early stages to metastasis, in hopes of creating highly personalized treatment strategies for patients who have cancer. The findings are published in Nature's new online journal Scientific Reports.

1 Aug 2011